{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:06:38Z","timestamp":1790805998282,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.xphs.2024.02.021","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T09:24:19Z","timestamp":1709198659000},"page":"2178-2187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Phospholipid Free Nano-Vesicles of Brinzolamide Biopolymer Ocular Insert; Design, In vitro and In vivo Evaluation"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6340-6700","authenticated-orcid":false,"given":"Mayssa Abdel","family":"Hady","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally A.","family":"El-Zahaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.xphs.2024.02.021_bib0001","article-title":"Epidemiology of glaucoma: the past, present, and predictions for the future","volume":"12","author":"Allison","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.xphs.2024.02.021_bib0002","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2147\/OPTH.S236030","article-title":"Current knowledge and attitudes concerning cost-effectiveness in glaucoma pharmacotherapy: a glaucoma specialists focus group study","volume":"14","author":"Feldman","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.xphs.2024.02.021_bib0003","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.2147\/DDDT.S399707","article-title":"A novel ocular delivery of brinzolamide based on gellan gum: in vitro and in vivo evaluation [retraction]","volume":"16","author":"Sun","year":"2022","journal-title":"Drug Des Devel Ther"},{"issue":"11","key":"10.1016\/j.xphs.2024.02.021_bib0004","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1007\/s12274-020-2980-9","article-title":"iRGD decorated liposomes: a novel actively penetrating topical ocular drug delivery strategy","volume":"13","author":"Huang","year":"2020","journal-title":"Nano Res"},{"issue":"3","key":"10.1016\/j.xphs.2024.02.021_bib0005","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1208\/s12249-015-0382-1","article-title":"Liposomes as a novel ocular delivery system for brinzolamide: in vitro and in vivo studies","volume":"17","author":"Li","year":"2016","journal-title":"AAPS PharmSciTech"},{"issue":"FEB","key":"10.1016\/j.xphs.2024.02.021_bib0006","article-title":"Nanoliposome-encapsulated brinzolamide-hydropropyl-\u03b2-cyclodextrin inclusion complex: a potential therapeutic ocular drug-delivery system","volume":"9","author":"Wang","year":"2018","journal-title":"Front Pharmacol"},{"issue":"8","key":"10.1016\/j.xphs.2024.02.021_bib0007","doi-asserted-by":"crossref","first-page":"8055","DOI":"10.1021\/acsnano.7b02702","article-title":"Design and characterization of a therapeutic non-phospholipid liposomal nanocarrier with osteoinductive characteristics to promote bone formation","volume":"11","author":"Cui","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.xphs.2024.02.021_bib0008","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2015.08.031","article-title":"Delivery of siRNA via cationic Sterosomes to enhance osteogenic differentiation of mesenchymal stem cells","volume":"217","author":"Cui","year":"2015","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.xphs.2024.02.021_bib0009","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/08982104.2019.1610434","article-title":"Design, optimization, characterization, and in vivo evaluation of sterosomes as a carrier of metformin for treatment of lung cancer","volume":"30","author":"Osama","year":"2020","journal-title":"J Liposome Res"},{"key":"10.1016\/j.xphs.2024.02.021_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.112304","article-title":"Design of transfersomal nanocarriers of nystatin for combating vulvovaginal candidiasis; a different prospective","volume":"211","author":"Hady","year":"2022","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1","key":"10.1016\/j.xphs.2024.02.021_bib0011","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/10717544.2021.1889720","article-title":"Nanophyto-gel against multi-drug resistant Pseudomonas aeruginosa burn wound infection","volume":"28","author":"Wen","year":"2021","journal-title":"Drug Deliv"},{"issue":"3","key":"10.1016\/j.xphs.2024.02.021_bib0012","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/10837450.2016.1219916","article-title":"Mucoadhesive niosomal in situ gel for ocular tissue targeting: in vitro and in vivo evaluation of lomefloxacin hydrochloride","volume":"22","author":"Abdelbary","year":"2017","journal-title":"Pharm Dev Technol"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2024.02.021_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(00)00508-1","article-title":"Ketorolac entrapped in polymeric micelles: preparation, characterisation and ocular anti-inflammatory studies","volume":"209","author":"Gupta","year":"2000","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2024.02.021_bib0014","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2478\/v10007-012-0002-5","article-title":"Design and evaluation of moxifloxacin hydrochloride ocular inserts","volume":"62","author":"Pawar","year":"2012","journal-title":"Acta Pharmaceutica"},{"issue":"7","key":"10.1016\/j.xphs.2024.02.021_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133149","article-title":"Ocular inserts for sustained release of the angiotensin-converting enzyme 2 activator, diminazene aceturate, to treat glaucoma in rats","volume":"10","author":"Foureaux","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.xphs.2024.02.021_bib0016","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jsps.2014.02.009","article-title":"Design and evaluation of gastroretentive levofloxacin floating mini-tablets-in-capsule system for eradication of Helicobacter pylori","volume":"22","author":"El-Zahaby","year":"2014","journal-title":"Saudi Pharmaceut J"},{"issue":"7","key":"10.1016\/j.xphs.2024.02.021_bib0017","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1208\/s12249-017-0710-8","article-title":"PLGA nanoparticles as subconjunctival injection for management of glaucoma","volume":"18","author":"Salama","year":"2017","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"10.1016\/j.xphs.2024.02.021_bib0018","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/IJG.0000000000001827","article-title":"Need for additional glaucoma surgery and complications following glaucoma drainage device surgery","volume":"30","author":"Kung","year":"2021","journal-title":"J Glaucoma"},{"issue":"2","key":"10.1016\/j.xphs.2024.02.021_bib0019","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal formulations in clinical use: an updated review","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.xphs.2024.02.021_bib0020","first-page":"59","article-title":"Proniosomal gel for transdermal delivery of lornoxicam: optimization using factorial design and in vivo evaluation in rats","volume":"27","author":"Shah","year":"2019","journal-title":"J Pharm Sci"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2024.02.021_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2009.04.020","article-title":"Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery","volume":"377","author":"Balakrishnan","year":"2009","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2024.02.021_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2005.02.021","article-title":"Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes","volume":"298","author":"L\u00f3pez-Pinto","year":"2005","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2024.02.021_bib0023","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s10971-020-05305-z","article-title":"Optimization and evaluation of encapsulated brimonidine tartrate-loaded nanoparticles incorporation in situ gel for efficient intraocular pressure reduction","volume":"95","author":"Sharma","year":"2020","journal-title":"J Solgel Sci Technol"},{"key":"10.1016\/j.xphs.2024.02.021_bib0024","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2147\/IJN.S126199","article-title":"Corneal permeation properties of a charged lipid nanoparticle carrier containing dexamethasone","volume":"12","author":"Ban","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.xphs.2024.02.021_bib0025","unstructured":"Shenoy SL, Painter PC, Coleman MM. The swelling and collapse of hydrogen bonded polymer gels."},{"issue":"1\u20132","key":"10.1016\/j.xphs.2024.02.021_bib0026","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0378-5173(95)04113-3","article-title":"A study of the hydrophilic cellulose matrix: effect of indomethacin and a water-soluble additive on swelling properties","volume":"126","author":"Panomsuk","year":"1995","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2024.02.021_bib0027","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4103\/0973-8398.84545","article-title":"Simvastatin-loaded PLGA nanoparticles for improved oral bioavailability and sustained release: effect of formulation variables","volume":"5","author":"Soni","year":"2011","journal-title":"Asian J Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2024.02.021_bib0028","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.actbio.2009.11.035","article-title":"A novel paclitaxel-loaded poly (\u03b5-caprolactone)\/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment","volume":"6","author":"Zhang","year":"2010","journal-title":"Acta Biomater"},{"issue":"7","key":"10.1016\/j.xphs.2024.02.021_bib0029","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1208\/s12249-017-0710-8","article-title":"PLGA nanoparticles as subconjunctival injection for management of glaucoma","volume":"18","author":"Salama","year":"2017","journal-title":"AAPS PharmSciTech"},{"issue":"18","key":"10.1016\/j.xphs.2024.02.021_bib0030","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.3390\/molecules25184330","article-title":"The efficacy of cholesterol-based carriers in drug delivery","volume":"25","author":"Ruwizhi","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.xphs.2024.02.021_bib0031","volume":"90","author":"Sakr","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2024.02.021_bib0032","article-title":"Fabrication of betaxolol hydrochloride-loaded highly permeable ocular bilosomes (HPOBs) to combat glaucoma: in vitro, ex vivo & in vivo characterizations","volume":"82","author":"Sakr","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2024.02.021_bib0033","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejps.2017.09.024","article-title":"Ophthalmic administration of a 10-fold-lower dose of conventional nanoliposome formulations caused levels of intraocular pressure similar to those induced by marketed eye drops","volume":"111","author":"Arroyo","year":"2018","journal-title":"Eur J Pharmaceut Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924000649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924000649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T06:48:15Z","timestamp":1724741295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354924000649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0022354924000649"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2024.02.021","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phospholipid Free Nano-Vesicles of Brinzolamide Biopolymer Ocular Insert; Design, In vitro and In vivo Evaluation","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2024.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}